T. Dlamini

Reply: How Do the New Definitions for Multidrug-Resistant Tuberculosis Treatment Outcomes Really Perform?

A. Telnov, M. Bonnet, F. Varaine, 2015, American journal of respiratory and critical care medicine.

Revised definitions of multidrug-resistant tuberculosis treatment outcomes: closer to the reality?

A. Telnov, M. Bonnet, F. Varaine, 2015, American journal of respiratory and critical care medicine.

A Critical Assessment of Trait versus Situationalist Positions and the NEO Personality Inventory (NEO-PI-R)

D. Mojtahedi, Nicole Sherretts, Saskia Ryan, 2017 .

High Prevalence of Multidrug-Resistant Tuberculosis, Swaziland, 2009–2010

S. Rüsch-Gerdes, E. Richter, M. Bonnet, 2012, Emerging infectious diseases.

The Basis and Structure of Attitudes: A Critical Evaluation of Experimental, Discursive, and Social Constructionist Psychological Perspectives

Saskia Ryan, D. Willmott, T. Dlamini, 2017 .

Outcomes of HIV-infected versus HIV-non-infected patients treated for drug-resistance tuberculosis: Multicenter cohort study

A. Telnov, M. Bonnet, F. Varaine, 2018, PloS one.

Detection of drug-resistant tuberculosis by Xpert MTB/RIF in Swaziland.

P. Beckert, S. Niemann, M. Merker, 2015, The New England journal of medicine.

What is the best culture conversion prognostic marker for patients treated for multidrug-resistant tuberculosis?

A. Telnov, M. Bonnet, F. Varaine, 2019, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Research Protocol - Effectiveness and safety of a simplified short regimen for Multidrug Resistant Tuberculosis treatment in Manzini Region, Swaziland

P. Hepple, S. Dietrich, K. Keus, 2014 .

Association of diabetes, smoking, and alcohol use with subclinical-to-symptomatic spectrum of tuberculosis in 16 countries: an individual participant data meta-analysis of national tuberculosis prevalence surveys

D. Lolong, S. Egwaga, A. Copas, 2023, EClinicalMedicine.